LEXICON PHARMACEUTICALS, INC. - 8-K Filing

Lexicon Pharmaceuticals reports Q3 2026 revenue of $11.3M and announces completion of SONATA-HCM Phase 3 enrollment. (Items: 2.02 Results of Operation and Financial ConditionOn November 5, 2026, we issued a press release to report our financial results for the quarter en, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No)

SEC EDGAR · November 5, 2026, 12:03 UTC

Tickers: $LXRX

Read the full article at SEC EDGAR

More Regulatory news

Boost Run Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
INTERFACE INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Neonode Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Virtuix Holdings Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:20 UTC
Neonode Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:18 UTC
Beyond Air, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:17 UTC
Carter Bankshares, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:12 UTC
Marvell Technology, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:11 UTC
VISHAY INTERTECHNOLOGY INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:11 UTC
LATTICE SEMICONDUCTOR CORP - 4 Filing SEC EDGAR · November 12, 2026, 14:10 UTC